EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models

Maaike Van Trimpont, Amanda M Schalk, Kenneth Hofkens, Evelien Peeters, Sara T'Sas, Katrien Vandemeulebroecke, Ying Su, Ashley De Loera, Alyssa Garcia, Hui Chen, Tim Lammens, Pieter Van Vlierberghe und 2 weitere

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2024.217404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Maaike Van Trimpont und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Institute Ghent (CRIG), Ghent, Belgium; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: Asparaginase, Antineoplastic Agents, Melanoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

L-asparaginase (L-ASNase) is crucial in treating pediatric acute lymphoblastic leukemia (ALL), but its use is hampered by side effects from the immunogenicity and L-glutaminase (L-GLNase) co-activity of FDA-approved bacterial L-ASNases, often leading to treatment discontinuation and poor outcomes. The toxicity of these L-ASNases makes them especially challenging to use in adult cancer patients. To overcome these issues, we developed EBD-200, a humanized guinea pig L-ASNase with low Km and no L-GLNase activity, eliminating glutamine-related toxicity. EBD-200 showed comparable anti-cancer effects to PEGylated L-ASNase in ASNSlow ALL, melanoma and liver cancer models, with improved tolerability. Its potent anti-cancer efficacy and enhanced safety profile suggest that EBD-200 could benefit ALL patients and broaden treatment options for ASNSlow solid cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsparaginaseAntineoplastic AgentsMelanomaPrecursor Cell Lymphoblastic Leukemia-LymphomaLiver NeoplasmsAnimalsHumansXenograft Model Antitumor AssaysCell Line, TumorGuinea PigsGlutaminaseMiceFemaleAspartate-Ammonia Ligase

Stichwörter der Autor:innen

(Max 7)ASNS(low) solid tumorsAcute lymphoblastic leukemiaAsparagine synthetaseLiver cancerMelanoma

Substanzen

AsparaginaseAntineoplastic AgentsGlutaminaseAspartate-Ammonia Ligase

Autor:innen und Institutionen

  • Cancer Research Institute Ghent (CRIG), Ghent, Belgium; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
  • Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, USA; Enzyme By Design Inc., Chicago, USA.
  • Cancer Research Institute Ghent (CRIG), Ghent, Belgium; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium; Department of Internal Medicine and Pediatric…
  • Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, USA.
  • Director, Mass Spectrometry Core, Research Resources Center, University of Illinois at Chicago, Chicago, USA.
  • Cancer Research Institute Ghent (CRIG), Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • BLRD VA

Zitieren

APA

Van Trimpont, M., Schalk, A. M., Hofkens, K., Peeters, E., T'Sas, S., Vandemeulebroecke, K., Su, Y., De Loera, A., Garcia, A., Chen, H., Lammens, T., Van Vlierberghe, P., Goossens, S., & Lavie, A. (2025). A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217404

Vancouver

Van Trimpont M, Schalk AM, Hofkens K, Peeters E, T'Sas S, Vandemeulebroecke K, et al. A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models. Cancer Letters. 2025. doi:10.1016/j.canlet.2024.217404

BibTeX
@article{VanTrimpont2025,
  author = {Van Trimpont, Maaike and Schalk, Amanda M and Hofkens, Kenneth and Peeters, Evelien and T'Sas, Sara and Vandemeulebroecke, Katrien and Su, Ying and De Loera, Ashley and Garcia, Alyssa and Chen, Hui and Lammens, Tim and Van Vlierberghe, Pieter and Goossens, Steven and Lavie, Arnon},
  title = {A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2024.217404}
}
Kostenlos starten →